source
- What health system execs are talking aboutEarlier this week, I swung by the American Hospital Association’s Leadership Summit in downtown Denver. When I wasn’t giving out ice cream recommendations, I was trying to get a sense of what hospi…Endpoints · 13d ago↗ source
- Veradermics keeps ‘momentum going’ as baldness drug helps women with hair lossThe Phase 2 data exceeded expectations, lifting company shares as high as nearly $130 apiece and building the case for what may be the first pill specifically approved for female pattern hair loss.BioPharma Dive · 13d ago↗ source
- Kelun pads efficacy profile of Merck-partnered ADC; Europe will have to wait for Boehringer's HernexeosPlus, news about Vogenx and Orakl Oncology. 🇨🇳 Kelun touts China data for sac-TMT: Kelun-Biotech announced on Tuesday that its Merck-partnered antibody-drug conjugate sacituzumab tirumotecan succ…